<DOC>
	<DOCNO>NCT02106585</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , PK ( Pharmacokinetics ) single oral dos JTT-251 healthy type 2 diabetes mellitus subject evaluate effect food PK JTT-251 healthy subject .</brief_summary>
	<brief_title>Study Safety , Tolerability Pharmacokinetics Single Oral JTT-251 Doses Healthy Type 2 Diabetic Subjects</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<criteria>Healthy Subject Cohorts : Healthy male female subject Body Mass Index ( BMI ) 19.0 31.0 kg/m2 ( inclusive ) Type 2 Diabetic Subject Cohorts : Male female Type 2 diabetic subject diagnose least 3 month BMI 25 40 kg/m2 ( inclusive ) Have glycosylated hemoglobin ( HbA1c ) &gt; 6.5 % ≤10.9 % ( inclusive ) treatment naïve respect hypoglycemic agent OR &gt; 6.5 % ≤10.0 % ( inclusive ) treat metformin Healthy Subject Cohorts : Known clinically relevant history presence significant respiratory , gastrointestinal , renal , hepatic , hematological , lymphatic , neurological , cardiovascular , psychiatric , musculoskeletal , genitourinary , immunological , metabolic , dermatological connective tissue disease Subjects systolic blood pressure &gt; 150 mmHg and/or diastolic blood pressure &gt; 90 mmHg Type 2 Diabetic Subject Cohorts : Subjects know medical history presence type 1 diabetes mellitus Subjects know medical history acute metabolic diabetic complication Subjects uncontrolled hypertension ( systolic blood pressure &gt; 160 mmHg and/or diastolic blood pressure &gt; 95 mmHg document ongoing treatment )</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>October 2014</verification_date>
	<keyword>Safety</keyword>
	<keyword>Tolerability</keyword>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Food-effect</keyword>
	<keyword>Diabetes</keyword>
</DOC>